Kellner's emotional inhibition scale: A clinimetric approach to alexithymia research

Psychotherapy and Psychosomatics

Volumn 80, Issue 6, 2011, Pages 335-344

  Grandi, Silvana ^a   Sirri, Laura ^a   Wise, Thomas N ^b   Tossani, Eliana ^a   Fava, Giovanni A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Affect; Alexithymia; Clinimetrics; Depression; Diagnostic Criteria for Psychosomatic Research; Emotional inhibition; Heart transplantation

Indexed keywords

ADULT; ALEXITHYMIA; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISGUISE OF FEELING; EMOTION; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; KELLNER EMOTIONAL INHIBITION SCALE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SELF CONCEPT; SELF CONTROL; STRUCTURED INTERVIEW; SYMPTOM QUESTIONNAIRE; TIMIDITY; VERBAL BEHAVIOR;

AFFECTIVE SYMPTOMS; DEPRESSION; DIAGNOSIS, DIFFERENTIAL; EMOTIONS; FEMALE; HEART TRANSPLANTATION; HUMANS; INHIBITION (PSYCHOLOGY); INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOPHYSIOLOGIC DISORDERS; SENSITIVITY AND SPECIFICITY;

EID: 79961099985     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000328576     Document Type: Article

References (105)

1. Sifneos PE: The prevalence of 'alexithymic' characteristics in psychosomatic patients. Psychother Psychosom 1973; 22: 255-262.
2. Sifneos PE: Alexithymia, clinical issues, politics and crime. Psychother Psychosom 2000; 69: 113-116. (Pubitemid 30223578)
3. Taylor GJ, Bagby RM, Parker JD: The alexithymia construct: a potential paradigm for psychosomatic medicine. Psychosomatics 1991; 32: 153-164.
4. Taylor GJ: Affects, trauma, and mechanisms of symptom formation: a tribute to John C. Nemiah, MD (1918-2009). Psychother Psychosom 2010; 79: 339-349.
5. Taylor GJ, Bagby RM: New trends in alexithymia research. Psychother Psychosom 2004; 73: 68-77. (Pubitemid 38223749)
6. Taylor GJ, Ryan D, Bagby RM: Toward the development of a new self-report alexithymia scale. Psychother Psychosom 1985; 44: 191-199. (Pubitemid 16092029)
7. Bagby RM, Parker JD, Taylor GJ: The twentyitem Toronto Alexithymia Scale-I: item selection and cross-validation of the factor structure. J Psychosom Res 1994; 38: 23-32.
8. Bagby RM, Taylor GJ, Parker JD: The twentyitem Toronto Alexithymia Scale-II: convergent, discriminant, and concurrent validity. J Psychosom Res 1994; 38: 33-40.
9. Bermond B, Vorst HC, Vingerhoets AJ, Gerritsen W: The Amsterdam Alexithymia Scale: its psychometric values and correlations with other personality traits. Psychother Psychosom 1999; 68: 241-251. (Pubitemid 29431611)
10. Vorst HC, Bermond B: Validity and reliability of the Bermond-Vorst Alexithymia Questionnaire. Pers Indiv Dif 2001; 30: 413-434. (Pubitemid 33630904)
11. Kleiger JH, Kinsman RA: The development of an MMPI alexithymia scale. Psychother Psychosom 1980; 34: 17-24. (Pubitemid 11220332)
12. Apfel RJ, Sifneos PE: Alexithymia: concept and measurement. Psychother Psychosom 1979; 32: 180-190. (Pubitemid 10045833)
13. Martin JB, Pihl RO, Dobkin P: Schalling-Sifneos personality scale: findings and recommendations. Psychother Psychosom 1984; 41: 145-152. (Pubitemid 14119567)
14. Bagby RM, Taylor GJ, Parker JD, Dickens SE: The development of the Toronto Structured Interview for Alexithymia: item selection, factor structure, reliability and concurrent validity. Psychother Psychosom 2006; 75: 25-39. (Pubitemid 41816062)
15. Haviland MG, Warren WL, Riggs ML: An observer scale to measure alexithymia. Psychosomatics 2000; 41: 385-392.
16. Cohen K, Auld F, Demers L, Catchlove R: Alexithymia: the development of a valid and reliable projective measure (the objectively scored Archetypal9 Test). J Nerv Ment Dis 1985; 173: 621-627. (Pubitemid 16237258)
17. Porcelli P, Meyer GJ: Construct validity of Rorschach variables for alexithymia. Psychosomatics 2002; 43: 360-369.
18. Porcelli P, Mihura JL: Assessment of alexithymia with the Rorschach Comprehensive System: the Rorschach Alexithymia Scale (RAS). J Pers Assess 2010; 92: 128-136.
19. Taylor GJ, Bagby RM: Measurement of alexithymia: recommendations for clinical practice and future research. Psychiatr Clin North Am 1988; 11: 351-366.
20. Kooiman CG, Spinhoven P, Trijsburg RW: The assessment of alexithymia: a critical review of the literature and a psychometric study of the Toronto Alexithymia Scale-20. J Psychosom Res 2002; 53: 1083-1090. (Pubitemid 36040657)
21. Müller J, Bühner M, Ellgring H: Is there a reliable factorial structure in the 20-item Toronto Alexithymia Scale? A comparison of factor models in clinical and normal adult samples. J Psychosom Res 2003; 55: 561-568. (Pubitemid 38199712)
22. Haviland MG, Reise SP: Structure of the twenty-item Toronto Alexithymia Scale. J Pers Assess 1996; 66: 116-125. (Pubitemid 26057142)
23. Loas G, Otmani O, Verrier A, Fremaux D, Marchand MP: Factor analysis of the French version of the 20-Item Toronto Alexithymia Scale (TAS-20). Psychopathology 1996; 29: 139-144. (Pubitemid 26130072)
24. Erni T, Lötscher K, Modestin J: Two-factor solution of the 20-item Toronto Alexithymia Scale confirmed. Psychopathology 1997; 30: 335-340. (Pubitemid 27528520)
25. Hintikka J, Honkalampi K, Lehtonen J, Viinamäki H: Are alexithymia and depression distinct or overlapping constructs? A study in a general population. Compr Psychiatry 2001; 42: 234-239. (Pubitemid 32410928)
26. Joukamaa M, Miettunen J, Kokkonen P, Koskinen M, Julkunen J, Kauhanen J, Jokelainen J, Veijola J, Läksy K, Järvelin MR: Psychometric properties of the Finnish 20-item Toronto Alexithymia Scale. Nord J Psychiatry 2001; 55: 123-127. (Pubitemid 32487601)
27. Wise TN, Jani NN, Kass E, Sonnenschein K, Mann LS: Alexithymia: relationship to severity of medical illness and depression. Psychother Psychosom 1988; 50: 68-71. (Pubitemid 19176650)
28. Honkalampi K, Hintikka J, Saarinen P, Lehtonen J, Viinamäki H: Is alexithymia a permanent feature in depressed patients? Psychother Psychosom 2000; 69: 303-308.
29. Honkalampi K, Koivumaa-Honkanen H, Tanskanen A, Hintikka J, Lehtonen J, Viinamäki H: Why do alexithymic features appear to be stable? A 12-month follow-up study of a general population. Psychother Psychosom 2001; 70: 247-253. (Pubitemid 32757400)
30. Honkalampi K, Lehto SM, Hintikka J, Koivumaa-Honkanen H, Niskanen L, Viinamäki H: Symptoms of depression and alexithymic burden in middle-aged men. Psychother Psychosom 2010; 79: 259-261.
31. Wise TN, Mann LS, Mitchell JD, Hryvniak M, Hill B: Secondary alexithymia: an empirical validation. Compr Psychiatry 1990; 31: 284-288. (Pubitemid 20333842)
32. Freyberger H: Supportive psychotherapeu-tic techniques in primary and secondary alexithymia. Psychother Psychosom 1977; 28: 337-342. (Pubitemid 8273280)
33. Engel GL, Schmale AH: Conservation-withdrawal: a primary regulatory process for organismic homeostasis. Ciba Found Symp 1972; 8: 57-75.
34. Sirri L, Grandi S, Fava GA: The Illness Attitude Scales: a clinimetric index for assessing hypochondriacal fears and beliefs. Psychother Psychosom 2008; 77: 337-350.
35. Fava GA, Ruini C, Rafanelli C: Psychometric theory is an obstacle to the progress of clinical research. Psychother Psychosom 2004; 73: 145-148. (Pubitemid 38437717)
36. Bech P: Fifty years with the Hamilton scales for anxiety and depression: a tribute to Max Hamilton. Psychother Psychosom 2009; 78: 202-211.
37. Fava GA, Sonino N: Psychosomatic assessment. Psychother Psychosom 2009; 78: 333-341.
38. Fava GA, Guidi J, Semprini F, Tomba E, Sonino N: Clinical assessment of allostatic load and clinimetric criteria. Psychother Psychosom 2010; 79: 280-284.
39. Fava GA, Rafanelli C, Tomba E: The clinical process in psychiatry: a clinimetric approach. J Clin Psychiatry, in press.
40. Pennebaker JW, Hughes CF, O'Heeron RC: The psychophysiology of confession: linking inhibitory and psychosomatic processes. J Pers Soc Psychol 1987; 52: 781-793.
41. Pennebaker JW, Kiecolt-Glaser JK, Glaser R: Disclosure of traumas and immune function: health implications for psychotherapy. J Consult Clin Psychol 1988; 56: 239-245.
42. Fava GA, Grandi S, Savron G, Bartolucci G, Santarsiero G, Trombini G, Orlandi C: Psychosomatic assessment of hirsute women. Psychother Psychosom 1989; 51: 96-100. (Pubitemid 20098116)
43. Saviotti FM, Grandi S, Savron G, Ermentini R, Bartolucci G, Conti S, Fava GA: Characterological traits of recovered patients with panic disorder and agoraphobia. J Affect Disord 1991; 23: 113-117.
44. Hollifield M, Tuttle L, Paine S, Kellner R: Hypochondriasis and somatization related to personality and attitudes toward self. Psychosomatics 1999; 40: 387-395. (Pubitemid 29407214)
45. Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, Wise TN: Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995; 63: 1-8.
46. Porcelli P, Rafanelli C: Criteria for psychosomatic research (DCPR) in the medical setting. Curr Psychiatry Rep 2010; 12: 246-254.
47. Wise TN: Diagnostic criteria for psychosomatic research are necessary for DSM V. Psychother Psychosom 2009; 78: 330-332.
48. Porcelli P, Sonino N (eds): Psychological Factors Affecting Medical Conditions: A New Classification for DSM-V. Adv Psychosom Med. Basel, Karger, 2007, vol 28, pp I-X.
49. Porcelli P, De Carne M, Fava GA: Assessing somatization in functional gastrointestinal disorders: integration of different criteria. Psychother Psychosom 2000; 69: 198-204. (Pubitemid 30413213)
50. Grandi S, Fabbri S, Tossani E, Mangelli L, Branzi A, Magelli C: Psychological evaluation after cardiac transplantation: the integration of different criteria. Psychother Psychosom 2001; 70: 176-183. (Pubitemid 32620183)
51. Grassi L, Sabato S, Rossi E, Biancosino B, Marmai L: Use of the diagnostic criteria for psychosomatic research in oncology. Psychother Psychosom 2005; 74: 100-107. (Pubitemid 40470262)
52. Grassi L, Mangelli L, Fava GA, Grandi S, Ottolini F, Porcelli P, Rafanelli C, Rigatelli M, Sonino N: Psychosomatic characterization of adjustment disorders in the medical setting: some suggestions for DSM-V. J Affect Disord 2007; 101: 251-254. (Pubitemid 46879926)
53. Galeazzi GM, Ferrari S, Mackinnon A, Rigatelli M: Interrater reliability, prevalence, and relation to ICD-10 diagnoses of the diagnostic criteria for psychosomatic research in consultation-liaison psychiatry patients. Psychosomatics 2004; 45: 386-393. (Pubitemid 39166910)
54. Porcelli P, Bellomo A, Quartesan R, Altamura M, Iuso S, Ciannameo I, Piselli M, Elisei S: Psychosocial functioning in consultationliaison psychiatry patients: influence of psychosomatic syndromes, psychopathology and somatization. Psychother Psychosom 2009; 78: 352-358.
55. Mangelli L, Semprini F, Sirri L, Fava GA, Sonino N: Use of the diagnostic criteria for psychosomatic research (DCPR) in a community sample. Psychosomatics 2006; 47: 143-146. (Pubitemid 43346962)
56. Fukunishi I, Hosaka T, Aoki T, Azekawa T, Ota A, Miyaoka H: Criterion-related validity of diagnostic criteria for alexithymia in a general hospital psychiatric setting. Psychother Psychosom 1996; 65: 82-85. (Pubitemid 26095800)
57. Porcelli P, De Carne M: Criterion-related validity of the diagnostic criteria for psychosomatic research for alexithymia in patients with functional gastrointestinal disorders. Psychother Psychosom 2001; 70: 184-188. (Pubitemid 32620184)
58. Beresnevaité M, Taylor GJ, Bagby RM: Assessing alexithymia and type A behavior in coronary heart disease patients: a multimethod approach. Psychother Psychosom 2007; 76: 186-192. (Pubitemid 46582023)
59. Bressi C, Taylor G, Parker J, Bressi S, Brambilla V, Aguglia E, Allegranti I, Bongiorno A, Giberti F, Bucca M, Todarello O, Callegari C, Vender S, Gala C, Invernizzi G: Cross validation of the factor structure of the 20-item Toronto Alexithymia Scale: an Italian multicenter study. J Psychosom Res 1996; 41: 551-559. (Pubitemid 27032928)
60. Kellner R: A symptom questionnaire. J Clin Psychiatry 1987; 48: 268-273.
61. Fava GA, Kellner R, Perini GI, Fava M, Michelacci L, Munari F, Evangelisti LP, Grandi S, Bernardi M, Mastrogiacomo I: Italian validation of the Symptom Rating Test (SRT) and Symptom Questionnaire (SQ). Can J Psychiatry 1983; 28: 117-123. (Pubitemid 13136240)
62. Fava GA, Kellner R, Lisansky J, Park S, Perini GI, Zielezny M: Rating depression in normals and depressives: observer versus selfrating scales. J Affect Disord 1986; 11: 29-33. (Pubitemid 16045972)
63. Pennebaker JW, Beall SK: Confronting a traumatic event: toward an understanding of inhibition and disease. J Abnorm Psychol 1986; 95: 274-281. (Pubitemid 17043226)
64. King LA, Emmons RA, Woodley S: The structure of inhibition. J Res Pers 1992; 26: 85-102.
65. Davies M, Stankov L, Roberts RD: Emotional intelligence: in search of an elusive construct. J Pers Soc Psychol 1998; 75: 989-1015.
66. Helmes E, McNeill PD, Holden RR, Jackson C: The construct of alexithymia: associations with defense mechanisms. J Clin Psychol 2008; 64: 318-331. (Pubitemid 351450387)
67. Verissimo R, Mota-Cardoso R, Taylor G: Relationships between alexithymia, emotional control, and quality of life in patients with inflammatory bowel disease. Psychother Psychosom 1998; 67: 75-80. (Pubitemid 28132533)
68. Myers LB: Alexithymia and repression: the role of defensiveness and trait anxiety. Pers Individ Dif 1995; 19: 489-492.
69. Martin JB, Pihl RO: Influence of alexithymic characteristics on physiological and subjective stress responses in normal individuals. Psychother Psychosom 1986; 45: 66-77.
70. Papciak AS, Feuerstein M, Spiegel JA: Stress reactivity in alexithymia: decoupling of physiological and cognitive responses. J Human Stress 1985; 11: 135-142. (Pubitemid 16158759)
71. Newton TL, Contrada RJ: Alexithymia and repression: contrasting emotion-focused coping styles. Psychosom Med 1994; 56: 457-462.
72. Dew MA: Quality-of-life studies: organ transplantation research as an exemplar of past progress and future directions. J Psychosom Res 1998; 44: 189-195.
73. Weisman AD, Hackett TP: Denial as a social act; in Levin S, Kahana R (eds): Psychodynamic Studies on Aging: Creativity, Reminiscing and Dying. New York, IUP, 1967, pp 79-110.
74. Michael YL, Wisdom JP, Perrin N, Bowen D, Cochrane BB, Brzyski R, Ritenbaugh C: Expression and ambivalence over expression of negative emotion: cross-sectional associations with psychosocial factors and healthrelated quality of life in postmenopausal women. J Women Aging 2006; 18: 25-40. (Pubitemid 44543538)
75. Iwamitsu Y, Shimoda K, Abe H, Tani T, Kodama M, Okawa M: Differences in emotional distress between breast tumor patients with emotional inhibition and those with emotional expression. Psychiatry Clin Neurosci 2003; 57: 289-294. (Pubitemid 36644415)
76. Iwamitsu Y, Shimoda K, Abe H, Tani T, Okawa M, Buck R: The relation between negative emotional suppression and emotional distress in breast cancer diagnosis and treatment. Health Commun 2005; 18: 201-215. (Pubitemid 43104482)
77. Jensen MR: Psychobiological factors predicting the course of breast cancer. J Pers 1987; 55: 317-342.
78. Giese-Davis J, DiMiceli S, Sephton S, Spiegel D: Emotional expression and diurnal cortisol slope in women with metastatic breast cancer in supportive-expressive group therapy: a preliminary study. Biol Psychol 2006; 73: 190-198. (Pubitemid 44062105)
79. Shaw RE, Cohen F, Doyle B, Palesky J: The impact of denial and repressive style on information gain and rehabilitation outcomes in myocardial infarction patients. Psychosom Med 1985; 47: 262-273. (Pubitemid 15028354)
80. Esterling BA, Antoni MH, Kumar M, Schneiderman N: Emotional repression, stress disclosure responses, and Epstein-Barr viral capsid antigen titers. Psychosom Med 1990; 52: 397-410. (Pubitemid 20234854)
81. King AC, Taylor CB, Albright CA, Haskell WL: The relationship between repressive and defensive coping styles and blood pressure responses in healthy, middle-aged men and women. J Psychosom Res 1990; 34: 461-471. (Pubitemid 20334637)
82. Niaura R, Herbert PN, McMahon N, Sommerville L: Repressive coping and blood lipids in men and women. Psychosom Med 1992; 54: 698-706.
83. Berry DS, Pennebaker JW: Nonverbal and verbal emotional expression and health. Psychother Psychosom 1993; 59: 11-19. (Pubitemid 23082148)
84. Gross JJ, Levenson RW: Hiding feelings: the acute effects of inhibiting negative and positive emotion. J Abnorm Psychol 1997; 106: 95-103. (Pubitemid 27063195)
85. Myers LB: The importance of the repressive coping style: findings from 30 years of research. Anxiety Stress Coping 2010; 23: 3-17.
86. Denollet J: Personality and risk of cancer in men with coronary heart disease. Psychol Med 1998; 28: 991-995. (Pubitemid 28393577)
87. Kupper N, Denollet J: Type D personality as a prognostic factor in heart disease: assessment and mediating mechanisms. J Pers Assess 2007; 89: 265-276. (Pubitemid 350274950)
88. Lumley MA, Stettner L, Wehmer F: How are alexithymia and physical illness linked? A review and critique of pathways. J Psychosom Res 1996; 41: 505-518. (Pubitemid 27032924)
89. Sifneos PE: Problems of psychotherapy of patients with alexithymic characteristics and physical disease. Psychother Psycho-som 1975; 26: 65-70.
90. Beresnevaité M: Exploring the benefits of group psychotherapy in reducing alexithymia in coronary heart disease patients: a preliminary study. Psychother Psychosom 2000; 69: 117-122. (Pubitemid 30223579)
91. Stingl M, Bausch S, Walter B, Kagerer S, Leichsenring F, Leweke F: Effects of inpatient psychotherapy on the stability of alexithymia characteristics. J Psychosom Res 2008; 65: 173-180.
92. Grabe HJ, Frommer J, Ankerhold A, Ulrich C, Groger R, Franke GH, Barnow S, Freyberger HJ, Spitzer C: Alexithymia and outcome in psychotherapy. Psychother Psychosom 2008; 77: 189-194. (Pubitemid 351442722)
93. Tulipani C, Morelli F, Spedicato MR, Maiello E, Todarello O, Porcelli P: Alexithymia and cancer pain: the effect of psychological intervention. Psychother Psychosom 2010; 79: 156-163.
94. Ogrodniczuk JS, Piper WE, Joyce AS, Abbass AA: Alexithymia and treatment preferences among psychiatric outpatients. Psychother Psychosom 2009; 78: 383-384.
95. Smyth JM: Written emotional expression: effect sizes, outcome types, and moderating variables. J Consult Clin Psychol 1998; 66: 174-184. (Pubitemid 28086820)
96. Frisina PG, Borod JC, Lepore SJ: A metaanalysis of the effects of written emotional disclosure on the health outcomes of clinical populations. J Nerv Ment Dis 2004; 192: 629-634. (Pubitemid 39238411)
97. Frattaroli J: Experimental disclosure and its moderators: a meta-analysis. Psychol Bull 2006; 132: 823-865. (Pubitemid 44665369)
98. van Middendorp H, Geenen R, Sorbi MJ, van Doornen LJ, Bijlsma JW: Health and physiological effects of an emotional disclosure intervention adapted for application at home: a randomized clinical trial in rheumatoid arthritis. Psychother Psychosom 2009; 78: 145-151.
99. Wise TN, Mann LS, Hill B: Alexithymia and depressed mood in the psychiatric patient. Psychother Psychosom 1990; 54: 26-31.
100. Parker JD, Bagby RM, Taylor GJ: Alexithymia and depression: distinct or overlapping constructs? Compr Psychiatry 1991; 32: 387-394.
101. Wise TN, Mann LS, Randell P: The stability of alexithymia in depressed patients. Psychopathology 1995; 28: 173-176.
102. Luminet O, Bagby RM, Taylor GJ: An evaluation of the absolute and relative stability of alexithymia in patients with major depression. Psychother Psychosom 2001; 70: 254-260. (Pubitemid 32757401)
103. Lynch TR, Robins CJ, Morse JQ, Krause ED: A mediational model relating affect intensity, emotional inhibition, and psychological distress. Behav Ther 2001; 32: 519-536. (Pubitemid 33001005)
104. Krause ED, Mendelson T, Lynch TR: Childhood emotional invalidation and adult psychological distress: the mediating role of emotional inhibition. Child Abuse Negl 2003; 27: 199-213. (Pubitemid 36293327)
105. Van Emmerik AA, Kamphuis JH, Emmelkamp PM: Treating acute stress disorder and posttraumatic stress disorder with cognitive behavioral therapy or structured writing therapy: a randomized controlled trial. Psychother Psychosom 2008; 77: 93-100. (Pubitemid 351172099)